Metronidazol Stada

Metronidazole, the active ingredient in Metronidazol Stada, is a nitroimidazole antibiotic presented as an oral dosage form for oral use. It treats anaerobic bacterial and protozoal infections in adults and adolescents. It is indicated for conditions such as bacterial vaginosis, trichomoniasis, amoebiasis, and various anaerobic infections. The drug is formulated for systemic absorption and is widely used in both outpatient and inpatient settings.

GNH USA supplies Metronidazol Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metronidazole is used to treat infections caused by anaerobic bacteria and susceptible protozoa.

- Bacterial vaginosis: eradicates Gardnerella vaginalis and restores normal vaginal flora. - Trichomoniasis: eliminates Trichomonas vaginalis, relieving symptoms and preventing recurrence. - Amoebiasis: clears intestinal Entamoeba histolytica infection, reducing dysentery and tissue invasion. - Intra‑abdominal anaerobic infections: controls mixed anaerobic bacterial populations, aiding resolution of abscesses. - Skin and soft‑tissue infections: manages anaerobic bacteria in cellulitis, abscesses and diabetic foot infections. - Clostridioides difficile infection (adjunct): reduces toxin‑producing bacterial load when used with standard therapy.

Metronidazole may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild stomach upset often occurring early in therapy. - Metallic taste: transient metallic sensation in the mouth. - Diarrhea: loose stools that resolve after discontinuation. - Headache: mild to moderate head pain.

Serious or Rare Side Effects: - Peripheral neuropathy: numbness or tingling in extremities that may be irreversible. - Seizures: rare convulsive episodes requiring immediate medical attention. - Severe allergic reaction: anaphylaxis or angioedema. - Hepatotoxicity: elevated liver enzymes or jaundice.

Before prescribing Metronidazol Stada, consider several safety aspects. - Pregnancy: use only if clearly needed; fetal risk not fully established. - Alcohol interaction: avoid alcohol to prevent a disulfiram‑like reaction. - Liver disease: monitor hepatic function and adjust dose if necessary. - Renal impairment: use with caution in severe renal failure. - Concomitant medications: review for potential interactions, especially anticoagulants. - Store at ambient temperature: keep below 25 °C, in the original pack, and protect from moisture.

Metronidazol Stada can interact with several drug classes.

Major Interactions (Avoid): - Alcohol: may cause severe flushing, tachycardia, and hypotension. - Warfarin: can increase anticoagulant effect, raising bleeding risk. - Lithium: may raise lithium levels, leading to toxicity.

Moderate Interactions (Monitor Closely): - Cimetidine: may increase metronidazole plasma concentrations. - Phenytoin: may reduce metronidazole levels, decreasing efficacy. - Oral contraceptives: may reduce effectiveness; advise additional contraceptive methods.